Luminnova Viral Defense Systems

To minimize suffering and disruption from respiratory viral infections, it’s crucial to take proactive measures, stay prepared, and respond quickly to any developing symptoms.

The Luminnova Viral Defense System is designed to optimize response in three key areas:

• Sporadic viral defense meaures

• Rapid response to symptoms for early intervention

• Preparedness for community-wide surges of severe viral illness

Sporadic Defense Measures

We caution against the continuous use of viral prophylactic measures, as they may interfere with the essential training of the innate immune system. A well-trained innate immune response strengthens the body’s first line of defense, allowing for a faster and more effective reaction to respiratory viral infections.

However, for individuals at high risk of rapidly progressive, severe symptoms, more frequent preventative measures may be necessary. For those at low to moderate risk, such measures are recommended only in specific higher risk situations, such as airline travel.

Rapid Response to Infection

The most effective way to combat viral infections is to begin treatment at the first signs of symptoms, before the virus multiplies exponentially. This is best achieved by having all necessary measures in place beforehand and having a clear idea of how to use them.

Severe Viral Surge Contingency

Many of the recent COVID-19 variants carry mutations similar to Delta, which can lead to severe lung disease and widespread infection. However, these virulent traits are currently being controlled by the immune system, resulting in mostly mild cases, though sporadic severe cases are on the rise.

COVID-19 continues to mutate, and a chance mutation that enables the virus to evade immune defenses could lead to severe, widespread infection, potentially rendering even rapid response measures insufficient. In such a scenario, ongoing prophylaxis would be necessary. If a large portion of the population is affected, supply chain disruptions could make it difficult to access essential medications. For this reason, we recommend keeping a three-month supply of prophylactic medication on hand.

The table below outlines the recommended strategies for each of these contexts:

Calcifediol Ultra

Low vitamin D levels significantly increase the risk of severe COVID-19, influenza, and other viral infections, as well as certain cancers and autoimmune diseases. Maintaining optimal levels is essential and can be achieved through sun exposure, a nutrient-rich diet, and supplementation with vitamin D3, along with key co-factors like vitamin K2, magnesium, and zinc.

Because D3 takes about two weeks to convert into its active form, high doses at the onset of infection may not provide immediate protection. Additionally, the body depletes vitamin D more rapidly when fighting infections, making consistent maintenance crucial.

Calcifediol: A Fast-Acting Alternative

Calcifediol, a more potent and fast-acting form of vitamin D, can raise levels within four hours, making it especially valuable for acute infections and severe deficiencies.

A 2020 study by Castillo demonstrated its effectiveness in hospitalized COVID-19 patients:

ICU Admission | Deaths

• Standard protocol only: 26 patients - thirteen admitted to ICU (50%) | Two deaths

• Standard protocol + calcifediol: 50 patients - one admitted to the ICU (2%) | Zero deaths

These findings highlight the critical role of maintaining adequate vitamin D levels in reducing severe infection risks.

antimicrobial blue light

Studies have shown that specific blue light wavelengths can inhibit viral replication, including SARS-CoV-2, influenza, and herpes simplex. In vitro research has demonstrated a 90–99% reduction in viable SARS-CoV-2 with active wavelengths and sufficient exposure times, an effect likely enhanced by natural photosensitizers on human mucosal surfaces.

Luminnova Health has developed a blue light probe designed for use at viral entry points in the nose and mouth immediately after high-risk exposures, potentially lowering viral load and reducing the risk of severe infection.

Hypochlorous Acid Spray & Nebulizer

Hypochlorous acid (HOCl) is a an activated saline solution which is highly effective and non-toxic. It rapidly neutralizes a wide variety of pathogens, including CoVID-19.

A clinical study conducted in Mexico confirmed the activity of hypochlorous acid in mitigating CoVID-19 symptoms and disease progression using inhaled, intravenous and orally ingested HOCl.

We advise use of hypochlorous acid sprays to the nose and mouth after higher risk exposures (close contact in a crowded, enclosed area) but not on a constant basis. Nebulized hypochlorous acid can reach the airways, more optimally targeting acute lung infections.

Oral/Nasal PDT

Activating methylene blue in the nose and mouth with red light can significantly lower viral load, reduce symptoms, and accelerate recovery—even in severe COVID-19. This was demonstrated in studies conducted in Germany and the Bahamas, the latter during the severe Delta wave, where PDT was combined with orally ingested methylene blue for enhanced efficacy.

While oral/nasal PDT is highly effective, it is more logistically complex than using the blue light probe. For high-risk individuals, we recommend using the blue light probe immediately after potential exposure, followed by oral/nasal PDT as soon as feasible (e.g., upon arriving home). For those at low to moderate risk, the blue light probe alone may suffice, and oral/nasal PDT can be used only if symptoms develop.

Luminnova Health’s PDT Devices

We have developed two devices for administering oral/nasal PDT:

1. Original Device – Used in the Bahamas study, this is a lower-cost, individual-use option with longer treatment times.

2. High-Powered Red/Near-Infrared Device – A more powerful and versatile option that shortens treatment time and can be shared. It can also be used over the sinuses (for sinusitis) and the sternum (to support immune function via the thymus and bone marrow).
   
   

PBM Pad

Photobiomodulation (PBM) is a form of light therapy which uses specific wavelengths of light to enhance cellular function and promote healing. PBM reduces inflammation and pain, accelerates tissue repair, improves circulation, boosts immune function, and supports brain health.

A randomized study found that chest PBM in hospitalized COVID-19 patients shortened hospital stays and significantly improved cardiopulmonary function, including oxygen saturation, tidal volume, respiratory pressures, heart rate, and blood pressure. It also helped restore normal white blood cell balance, including lymphocytes and neutrophils.

Luminnova Health utilizes a compact, wireless PBM pad to support lung recovery and the healing of other organ systems.

Methylene Blue capsules

Methylene blue, recognized by the WHO as an essential medicine, has been safely used for nearly a century to save millions of lives.

In our experience, it is the most rapidly effective treatment for severe COVID-19, aligning with an Iranian study that found it significantly improved oxygen levels, reduced respiratory distress, and shortened hospital stays. Our published study on the Luminnova COVID-19 treatment protocol also documented rapid symptom reversal and oxygen level improvements during the severe Delta wave— achieved with just two key measures: methylene blue and red light therapy.

Methylene blue should not be taken with certain prescription drugs (especially serotonin agonists) and requires caution in G6PD deficiency, particularly with long-term use. Luminnova Health has sourced pure, pharmaceutical-grade methylene blue, free of heavy metals and other contaminants.

* Note: ivermectin will be substituted if methylene blue is contraindicated due to your current medications

N-ACETYL CYSTEINE

NAC has been safely used for years to prevent liver failure from acetaminophen overdose and is widely used for respiratory conditions.

A 2023 meta-analysis confirmed that “NAC reduces severity and mortality in COVID-19 patients,” likely due to its key actions:

• N-AC is a precursor to glutathione, a master antioxidant which is generated and tightly regulated by our cells for optimal response

• N-AC is a well established mucolytic (reduces and clears mucous from the airways)

• N-AC also reduces viral replication

In a six-month study on H1N1 influenza, infection rates were similar between NAC and control groups, but only 25% of NAC-treated individuals developed flu symptoms compared to 79% in the placebo group, demonstrating significant protection.

For individuals experiencing significant lung congestion, Luminnova Health recommends NAC Matrix, a specialized blend of pure NAC with added glycine and selenium to support optimal glutathione production, detoxification, and the clearance of excess mucus from the lungs.

Ivermectin

Ivermectin, introduced in the 1970s as an antiparasitic drug, transformed the treatment of diseases like river blindness and lymphatic filariasis. Its impressive safety profile and effectiveness led to its inclusion in the WHO List of Essential Medicines and earned its developers the 2015 Nobel Prize in Physiology or Medicine.

While its role in COVID-19 and other viral infections remains controversial, a large group of pre-clinical and clinical studies have demonstrated efficacy. Moreover it has been highly beneficial in our experience, particularly when methylene blue is not an option. With its affordability, strong safety profile, and minimal drug interactions, ivermectin is also well-suited for extended use as a prophylactic medication.

CAUTION: With the exception of persons at very high risk, long term prophylaxis should generally be avoided to allow training of the innate immune system. However it may well be required for persons at risk in the event of a virulent viral surge. We recommend keeping a three-month supply on hand as supplies may be limited or unavailable at that point. Ivermectin dosage is based on body weight.

How to Get started

If you would like to commence one of Viral Defense protocols, click this link to contact Luminnova Health and complete the questionnaire below.